KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
1-Year Return 19.71%
This Quarter Return
+9.39%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$189M
AUM Growth
+$8.05M
Cap. Flow
-$9.23M
Cap. Flow %
-4.88%
Top 10 Hldgs %
86.14%
Holding
16
New
2
Increased
6
Reduced
6
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$17.3B
$29.1M 15.38%
101,146
+2,918
+3% +$838K
CAH icon
2
Cardinal Health
CAH
$36.1B
$22.5M 11.89%
133,745
-55,000
-29% -$9.24M
EXEL icon
3
Exelixis
EXEL
$10B
$21.8M 11.51%
493,526
-385,007
-44% -$17M
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$7.87B
$17.5M 9.26%
164,816
+64,113
+64% +$6.8M
ENTA icon
5
Enanta Pharmaceuticals
ENTA
$184M
$16M 8.46%
2,114,444
-2,142
-0.1% -$16.2K
SUPN icon
6
Supernus Pharmaceuticals
SUPN
$2.53B
$14.9M 7.88%
472,376
+40,390
+9% +$1.27M
INDV icon
7
Indivior
INDV
$3.1B
$14.4M 7.6%
974,474
+9,106
+0.9% +$134K
GSK icon
8
GSK
GSK
$79.7B
$10.4M 5.52%
271,729
-271
-0.1% -$10.4K
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.42B
$8.49M 4.49%
958,877
+8,877
+0.9% +$78.6K
BNTX icon
10
BioNTech
BNTX
$24.3B
$7.81M 4.14%
73,382
-14,181
-16% -$1.51M
SNY icon
11
Sanofi
SNY
$113B
$7.2M 3.81%
148,946
-150
-0.1% -$7.25K
JNJ icon
12
Johnson & Johnson
JNJ
$430B
$6.11M 3.23%
+40,000
New +$6.11M
ALKS icon
13
Alkermes
ALKS
$4.78B
$5.95M 3.15%
207,822
VNDA icon
14
Vanda Pharmaceuticals
VNDA
$274M
$4.84M 2.56%
1,024,883
+270,502
+36% +$1.28M
REGN icon
15
Regeneron Pharmaceuticals
REGN
$60.5B
$2.1M 1.11%
+4,000
New +$2.1M
MURA icon
16
Mural Oncology
MURA
$36M
-70,263
Closed -$89K